Clinical Trial

Exploration of Manidipine to Reverse Aortic Valve Calcification

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated July 29, 2025 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a prospective, randomized, comparative, clinical trial conducted by Wuhan Union Hospital that aims to evaluate the efficacy and safety of manidipine compared to placebo in patients with calcific aortic valve disease with mild aortic valve stenosis.
Trial Details
NCT Number NCT07091136
Lead Sponsor Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Conditions Calcific Aortic Valve Disease
Enrollment 100 participants
Start Date 2025-08-01
Primary Completion 2026-08-01 (estimated)
Study Completion 2026-10-31 (estimated)
Updated on ClinicalTrials.gov 2025-07-29